 carboplatin childhood brain tumor children cancer studi group phase II trial octob march children cancer studi group institut patient recurr brain tumor phase II trial carboplatin week complet partial respons evalu children brainstem glioma ependymoma medulloblastoma central nervou system primit neuroectoderm tumor pnet none high-grad astrocytoma children medulloblastoma ependymoma central nervou system pnet prior cisplatin exposur respons prior cisplatin exposur respons thirty-four percent patient absolut neutrophil count platelet count sixteen percent moder sever otox nausea vomit none nephrotox